Renal Cancer - Results from #620

Impact of Prior Cytoreductive Nephrectomy on Efficacy in Patients with Synchronous Metastatic Renal Cell Carcinoma Treated with Avelumab plus Axitinib or Sunitinib: Post Hoc Analysis from the JAVELIN Renal 101 Phase 3 Trial. October 20, 2023

Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options. October 20, 2023

Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma. October 19, 2023

A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma. October 19, 2023

A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report. October 18, 2023

Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial. October 18, 2023

Artificial Intelligence in Surgical Training for Kidney Cancer: A Systematic Review of the Literature. October 17, 2023

Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma. October 17, 2023

18F-fluoro-2-deoxy-2-d-glucose PET-CT (FDG PET-CT) in staging of high-risk renal and urothelial bladder cancers (COPPER-T) trial protocol. October 16, 2023

2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race. October 16, 2023

Adverse Events of Cabozantinib Plus Nivolumab Versus Ipilimumab Plus Nivolumab. October 13, 2023

An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma. October 13, 2023

Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era. October 12, 2023

Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions. October 12, 2023

Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small (< 4 cm) clear cell renal cell carcinoma. October 11, 2023

Advancing Treatment Frontiers: Radiofrequency Ablation for Small Renal Mass-Intermediate-Term Results. October 11, 2023

Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy. October 10, 2023

The National Utilization of Non-Operative Management for Small Renal Masses Over 10 Years. October 10, 2023

Evaluation of local control after percutaneous microwave ablation versus partial nephrectomy: A propensity score matched study. October 9, 2023

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment. October 9, 2023

Page 32 of 453